BioCentury | Jul 30, 2019
Financial News

June 30 Financial Quick Takes: $40M series B for Hinova; plus TriArm and PredictImmune raise rounds

...round led by Panacea Venture and Virtus Inspire Ventures with participation by Efung Capital and Lombard Odier...
BioCentury | Aug 11, 2017
Company News

Management tracks: Orchard, Maverick, Pieris

...Pharmaceuticals Inc. (NASDAQ:PIRS) named Allan Reine SVP and CFO. He was a portfolio manager at Lombard Odier...
BioCentury | Feb 8, 2010
Finance

Golden oldies

...With an eye to the aging population, Lombard Odier launched its Golden Age fund, which will invest...
...data, but hedge or sell before Phase III, then re-enter post-pivotal data." Patricelli added that Lombard Odier...
BioCentury | Feb 8, 2010
Financial News

Lombard Odier Darier Hentsch & Cie financial update

...the MSCI World Healthcare Index and will be managed by lead portfolio manager Jim Patricelli. Lombard Odier...
BioCentury | Feb 3, 2010
Financial News

Lombard Odier launches fund

Lombard Odier, the Swiss private bank, launched its Golden Age fund, which will invest in public healthcare companies focused on the aging population. The fund, which attracted more than EUR 100 million ($139 million) at...
BioCentury | Nov 2, 2009
Finance

Ebb & Flow

...pre-money valuation in the current market environment." One of the transactions was with Swiss bank Lombard Odier...
BioCentury | Sep 28, 2009
Finance

Ebb & Flow

...promoted to co-managers of BB Biotech. Prior to that, Kosar was a portfolio manager for Lombard Odier...
BioCentury | Apr 17, 2008
Financial News

Paratek raises $18 million

...tranche: D.E. Shaw Group; Boston Life Science; Nomura Phase4; Novartis BioVenture Fund; BioFund; HBM BioVentures; Lombard Odier...
BioCentury | Mar 24, 2008
Finance

Nomura's investments

...on therapeutics that combat antibiotic resistance 2000 $20M series C, 2000 BankInvest; BioFund; FSC Corp.; Lombard Odier...
...D, 2002 BankInvest; BioFund; BioVeda; China Development Industrial Bank; GeneChem Therapeutic Venture Fund; HBM BioVentures; Lombard Odier...
...BioFund; Boston Life Science Corp.; BioVeda; D.E. Shaw Group; HBM BioVentures; Hercules Technology Growth Capital; Lombard Odier...
BioCentury | Oct 26, 2007
Financial News

Paratek raises $22 million

...and Boston Life Science joined existing investors Nomura Phase4; Novartis BioVenture Fund; BioFund; HBM BioVentures; Lombard Odier...
Items per page:
1 - 10 of 135
BioCentury | Jul 30, 2019
Financial News

June 30 Financial Quick Takes: $40M series B for Hinova; plus TriArm and PredictImmune raise rounds

...round led by Panacea Venture and Virtus Inspire Ventures with participation by Efung Capital and Lombard Odier...
BioCentury | Aug 11, 2017
Company News

Management tracks: Orchard, Maverick, Pieris

...Pharmaceuticals Inc. (NASDAQ:PIRS) named Allan Reine SVP and CFO. He was a portfolio manager at Lombard Odier...
BioCentury | Feb 8, 2010
Finance

Golden oldies

...With an eye to the aging population, Lombard Odier launched its Golden Age fund, which will invest...
...data, but hedge or sell before Phase III, then re-enter post-pivotal data." Patricelli added that Lombard Odier...
BioCentury | Feb 8, 2010
Financial News

Lombard Odier Darier Hentsch & Cie financial update

...the MSCI World Healthcare Index and will be managed by lead portfolio manager Jim Patricelli. Lombard Odier...
BioCentury | Feb 3, 2010
Financial News

Lombard Odier launches fund

Lombard Odier, the Swiss private bank, launched its Golden Age fund, which will invest in public healthcare companies focused on the aging population. The fund, which attracted more than EUR 100 million ($139 million) at...
BioCentury | Nov 2, 2009
Finance

Ebb & Flow

...pre-money valuation in the current market environment." One of the transactions was with Swiss bank Lombard Odier...
BioCentury | Sep 28, 2009
Finance

Ebb & Flow

...promoted to co-managers of BB Biotech. Prior to that, Kosar was a portfolio manager for Lombard Odier...
BioCentury | Apr 17, 2008
Financial News

Paratek raises $18 million

...tranche: D.E. Shaw Group; Boston Life Science; Nomura Phase4; Novartis BioVenture Fund; BioFund; HBM BioVentures; Lombard Odier...
BioCentury | Mar 24, 2008
Finance

Nomura's investments

...on therapeutics that combat antibiotic resistance 2000 $20M series C, 2000 BankInvest; BioFund; FSC Corp.; Lombard Odier...
...D, 2002 BankInvest; BioFund; BioVeda; China Development Industrial Bank; GeneChem Therapeutic Venture Fund; HBM BioVentures; Lombard Odier...
...BioFund; Boston Life Science Corp.; BioVeda; D.E. Shaw Group; HBM BioVentures; Hercules Technology Growth Capital; Lombard Odier...
BioCentury | Oct 26, 2007
Financial News

Paratek raises $22 million

...and Boston Life Science joined existing investors Nomura Phase4; Novartis BioVenture Fund; BioFund; HBM BioVentures; Lombard Odier...
Items per page:
1 - 10 of 135